Showing results (1621-1630 of 2,693) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|June 3, 2019
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)Per Ljungman, Rafael de la Camara, Christine Robin, et al.
The Lancet. Infectious Diseases|October 1, 2018
The temporal relationship between onchocerciasis and epilepsy: a population-based cohort studyCédric B Chesnais, Hugues C Nana-Djeunga, Alfred K Njamnshi, et al.
The Lancet. Infectious Diseases|October 8, 2018
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trialPatrick Jault, Thomas Leclerc, Serge Jennes, et al.
The Lancet. Infectious Diseases|March 10, 2022
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safeHannah G Rosenblum, Julianne Gee, Ruiling Liu, et al.
The Lancet. Infectious Diseases|March 14, 2022
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 studyJames Welker, Juan D Pulido, Andrew T Catanzaro, et al.
The Lancet. Infectious Diseases|March 5, 2022
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection studyBridget E Barber, Melissa Fernandez, Hardik Babubhai Patel, et al.
The Lancet. Infectious Diseases|March 6, 2022
Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic reviewSaartje Uyttebroek, Baixing Chen, Jolien Onsea, et al.
The Lancet. Infectious Diseases|March 6, 2022
25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forwardAnna S Dean, Olga Tosas Auguet, Philippe Glaziou, et al.
The Lancet. Infectious Diseases|January 23, 2021
Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational studyJamie Strampe, Danny A Asogun, Emily Speranza, et al.
The Lancet. Infectious Diseases|January 30, 2021
Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database studyHouyu Zhao, Li Wei, Hui Li, et al.
Pageof 270